ESTRO 2024 - Abstract Book

S1786

Clinical - Lung

ESTRO 2024

Conclusion:

Several dosimetric parameters were associated with an increased incidence of non-coronary CV events in our patients' cohort. The strongest predictor was V45 Gy (cut-off value 11%). Further prospective evaluation in a larger cohort of patients is warranted.

Keywords: NSCLC; Cardiac Toxicity; Chemoradiotherapy